Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,030.00
+630.00 (9.84%)
At close: Mar 6, 2026

Genome & Company Market Cap

Genome & Company has a market cap or net worth of 245.30 billion as of March 9, 2026. Its market cap has increased by 181.10% in one year.

Market Cap
245.30B
Enterprise Value
234.43B
Revenue
25.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,030.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 245.30B, an increase of 241.27%. That is a compound annual growth rate of 18.60%.

History

DateMarket Cap% Change
Mar 6, 2026245.30B2.90%
Dec 30, 2025238.38B179.77%
Dec 30, 202485.21B-51.64%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
ISU Abxis 204.82B
Bio Solution 244.14B
Prestige Biologics 200.60B
ABION 254.54B
Ensol Biosciences 192.90B
Kangstem Biotech 189.05B
TiumBio 186.10B
QuadMedicine 182.57B
Market Cap Rankings